| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:PRKAR1A-NDFIP2 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: PRKAR1A-NDFIP2 | FusionPDB ID: 68659 | FusionGDB2.0 ID: 68659 | Hgene | Tgene | Gene symbol | PRKAR1A | NDFIP2 | Gene ID | 5573 | 54602 |
| Gene name | protein kinase cAMP-dependent type I regulatory subunit alpha | Nedd4 family interacting protein 2 | |
| Synonyms | ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 | N4WBP5A | |
| Cytomap | 17q24.2 | 13q31.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cAMP-dependent protein kinase type I-alpha regulatory subunitCarney complex type 1cAMP-dependent protein kinase regulatory subunit RIalphacAMP-dependent protein kinase type I-alpha regulatory chainepididymis secretory sperm binding proteinprotein kin | NEDD4 family-interacting protein 2MAPK-activating protein PM04 PM05 PM06 PM07NEDD4 WW domain-binding protein 5ANF-kappa-B-activating protein 413putative MAPK-activating protein PM04/PM05/PM06/PM07putative NF-kappa-B-activating protein 413 | |
| Modification date | 20200329 | 20200313 | |
| UniProtAcc | P10644 | Q9NV92 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000358598, ENST00000392711, ENST00000536854, ENST00000586397, ENST00000588188, ENST00000589228, | ENST00000494647, ENST00000218652, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 15 X 15 X 8=1800 | 4 X 2 X 4=32 |
| # samples | 18 | 4 | |
| ** MAII score | log2(18/1800*10)=-3.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: PRKAR1A [Title/Abstract] AND NDFIP2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PRKAR1A(66511717)-NDFIP2(80094945), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | PRKAR1A-NDFIP2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PRKAR1A-NDFIP2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PRKAR1A-NDFIP2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PRKAR1A-NDFIP2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | PRKAR1A | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity | 21812984 |
| Fusion gene breakpoints across PRKAR1A (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across NDFIP2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-D7-A4Z0-01A | PRKAR1A | chr17 | 66511717 | + | NDFIP2 | chr13 | 80094945 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000358598 | PRKAR1A | chr17 | 66511717 | + | ENST00000218652 | NDFIP2 | chr13 | 80094945 | + | 4546 | 294 | 117 | 983 | 288 |
| ENST00000392711 | PRKAR1A | chr17 | 66511717 | + | ENST00000218652 | NDFIP2 | chr13 | 80094945 | + | 4613 | 361 | 184 | 1050 | 288 |
| ENST00000589228 | PRKAR1A | chr17 | 66511717 | + | ENST00000218652 | NDFIP2 | chr13 | 80094945 | + | 4557 | 305 | 56 | 994 | 312 |
| ENST00000536854 | PRKAR1A | chr17 | 66511717 | + | ENST00000218652 | NDFIP2 | chr13 | 80094945 | + | 4667 | 415 | 205 | 1104 | 299 |
| ENST00000586397 | PRKAR1A | chr17 | 66511717 | + | ENST00000218652 | NDFIP2 | chr13 | 80094945 | + | 5008 | 756 | 528 | 1445 | 305 |
| ENST00000588188 | PRKAR1A | chr17 | 66511717 | + | ENST00000218652 | NDFIP2 | chr13 | 80094945 | + | 4429 | 177 | 0 | 866 | 288 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000358598 | ENST00000218652 | PRKAR1A | chr17 | 66511717 | + | NDFIP2 | chr13 | 80094945 | + | 0.000130378 | 0.9998696 |
| ENST00000392711 | ENST00000218652 | PRKAR1A | chr17 | 66511717 | + | NDFIP2 | chr13 | 80094945 | + | 0.000133387 | 0.9998666 |
| ENST00000589228 | ENST00000218652 | PRKAR1A | chr17 | 66511717 | + | NDFIP2 | chr13 | 80094945 | + | 0.000129821 | 0.9998702 |
| ENST00000536854 | ENST00000218652 | PRKAR1A | chr17 | 66511717 | + | NDFIP2 | chr13 | 80094945 | + | 0.000132437 | 0.99986756 |
| ENST00000586397 | ENST00000218652 | PRKAR1A | chr17 | 66511717 | + | NDFIP2 | chr13 | 80094945 | + | 0.000121168 | 0.99987876 |
| ENST00000588188 | ENST00000218652 | PRKAR1A | chr17 | 66511717 | + | NDFIP2 | chr13 | 80094945 | + | 0.000122516 | 0.99987745 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >68659_68659_1_PRKAR1A-NDFIP2_PRKAR1A_chr17_66511717_ENST00000358598_NDFIP2_chr13_80094945_ENST00000218652_length(amino acids)=288AA_BP=48 MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKLLNEEDNSESSAIEQPPTSNPAPQIVQAASS APALETDSSPPPYSSITVEVPTTSDTEVYGEFYPVPPPYSVATSLPTYDEAEKAKAAAMAAAAAETSQRIQEEECPPRDDFSDADQLRVG NDGIFMLAFFMAFIFNWLGFCLSFCITNTIAGRYGAICGFGLSLIKWILIVRFSDYFTGYFNGQYWLWWIFLVLGLLLFFRGFVNYLKVR -------------------------------------------------------------- >68659_68659_2_PRKAR1A-NDFIP2_PRKAR1A_chr17_66511717_ENST00000392711_NDFIP2_chr13_80094945_ENST00000218652_length(amino acids)=288AA_BP=48 MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKLLNEEDNSESSAIEQPPTSNPAPQIVQAASS APALETDSSPPPYSSITVEVPTTSDTEVYGEFYPVPPPYSVATSLPTYDEAEKAKAAAMAAAAAETSQRIQEEECPPRDDFSDADQLRVG NDGIFMLAFFMAFIFNWLGFCLSFCITNTIAGRYGAICGFGLSLIKWILIVRFSDYFTGYFNGQYWLWWIFLVLGLLLFFRGFVNYLKVR -------------------------------------------------------------- >68659_68659_3_PRKAR1A-NDFIP2_PRKAR1A_chr17_66511717_ENST00000536854_NDFIP2_chr13_80094945_ENST00000218652_length(amino acids)=299AA_BP=59 MTSAPVSAERTMESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKLLNEEDNSESSAIEQPPTSN PAPQIVQAASSAPALETDSSPPPYSSITVEVPTTSDTEVYGEFYPVPPPYSVATSLPTYDEAEKAKAAAMAAAAAETSQRIQEEECPPRD DFSDADQLRVGNDGIFMLAFFMAFIFNWLGFCLSFCITNTIAGRYGAICGFGLSLIKWILIVRFSDYFTGYFNGQYWLWWIFLVLGLLLF -------------------------------------------------------------- >68659_68659_4_PRKAR1A-NDFIP2_PRKAR1A_chr17_66511717_ENST00000586397_NDFIP2_chr13_80094945_ENST00000218652_length(amino acids)=305AA_BP=65 MLYSLYKHVCVFFSQRTMESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKLLNEEDNSESSAIE QPPTSNPAPQIVQAASSAPALETDSSPPPYSSITVEVPTTSDTEVYGEFYPVPPPYSVATSLPTYDEAEKAKAAAMAAAAAETSQRIQEE ECPPRDDFSDADQLRVGNDGIFMLAFFMAFIFNWLGFCLSFCITNTIAGRYGAICGFGLSLIKWILIVRFSDYFTGYFNGQYWLWWIFLV -------------------------------------------------------------- >68659_68659_5_PRKAR1A-NDFIP2_PRKAR1A_chr17_66511717_ENST00000588188_NDFIP2_chr13_80094945_ENST00000218652_length(amino acids)=288AA_BP=48 MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKLLNEEDNSESSAIEQPPTSNPAPQIVQAASS APALETDSSPPPYSSITVEVPTTSDTEVYGEFYPVPPPYSVATSLPTYDEAEKAKAAAMAAAAAETSQRIQEEECPPRDDFSDADQLRVG NDGIFMLAFFMAFIFNWLGFCLSFCITNTIAGRYGAICGFGLSLIKWILIVRFSDYFTGYFNGQYWLWWIFLVLGLLLFFRGFVNYLKVR -------------------------------------------------------------- >68659_68659_6_PRKAR1A-NDFIP2_PRKAR1A_chr17_66511717_ENST00000589228_NDFIP2_chr13_80094945_ENST00000218652_length(amino acids)=312AA_BP=72 MRELGTPPPRTRSLAPAAARPQRTMESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKLLNEEDN SESSAIEQPPTSNPAPQIVQAASSAPALETDSSPPPYSSITVEVPTTSDTEVYGEFYPVPPPYSVATSLPTYDEAEKAKAAAMAAAAAET SQRIQEEECPPRDDFSDADQLRVGNDGIFMLAFFMAFIFNWLGFCLSFCITNTIAGRYGAICGFGLSLIKWILIVRFSDYFTGYFNGQYW -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:66511717/chr13:80094945) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PRKAR1A | NDFIP2 |
| FUNCTION: Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. {ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:20215566, ECO:0000269|PubMed:26405036}. | FUNCTION: Activates HECT domain-containing E3 ubiquitin-protein ligases, including ITCH, NEDD4, NEDD4L, SMURF2, WWP1 and WWP2, and consequently modulates the stability of their targets. As a result, may control many cellular processes. Recruits ITCH, NEDD4 and SMURF2 to endosomal membranes. Negatively regulates KCNH2 potassium channel activity by decreasing its cell-surface expression and interfering with channel maturation through recruitment of NEDD4L to the Golgi apparatus and multivesicular body where it mediates KCNH2 degradation (PubMed:26363003). May modulate EGFR signaling. Together with NDFIP1, limits the cytokine signaling and expansion of effector Th2 T-cells by promoting degradation of JAK1, probably by ITCH- and NEDD4L-mediated ubiquitination (By similarity). {ECO:0000250|UniProtKB:Q91ZP6, ECO:0000269|PubMed:12761501, ECO:0000269|PubMed:19343052, ECO:0000269|PubMed:20534535, ECO:0000269|PubMed:26363003}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 148_151 | 107.0 | 1399.3333333333333 | Motif | Note=PPxY motif 1 | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 174_177 | 107.0 | 1399.3333333333333 | Motif | Note=PPxY motif 2 | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 184_186 | 107.0 | 1399.3333333333333 | Motif | Note=PPxY motif 3 | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 253_257 | 107.0 | 1399.3333333333333 | Topological domain | Extracellular | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 279_287 | 107.0 | 1399.3333333333333 | Topological domain | Cytoplasmic | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 309_336 | 107.0 | 1399.3333333333333 | Topological domain | Extracellular | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 232_252 | 107.0 | 1399.3333333333333 | Transmembrane | Helical | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 258_278 | 107.0 | 1399.3333333333333 | Transmembrane | Helical | |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 288_308 | 107.0 | 1399.3333333333333 | Transmembrane | Helical |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000358598 | + | 2 | 11 | 96_100 | 59.0 | 382.0 | Motif | Note=Pseudophosphorylation motif |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000392711 | + | 2 | 11 | 96_100 | 59.0 | 382.0 | Motif | Note=Pseudophosphorylation motif |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000536854 | + | 3 | 12 | 96_100 | 59.0 | 382.0 | Motif | Note=Pseudophosphorylation motif |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000586397 | + | 1 | 10 | 96_100 | 59.0 | 382.0 | Motif | Note=Pseudophosphorylation motif |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000589228 | + | 2 | 11 | 96_100 | 59.0 | 382.0 | Motif | Note=Pseudophosphorylation motif |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000358598 | + | 2 | 11 | 137_254 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 1 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000358598 | + | 2 | 11 | 255_381 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 2 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000392711 | + | 2 | 11 | 137_254 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 1 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000392711 | + | 2 | 11 | 255_381 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 2 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000536854 | + | 3 | 12 | 137_254 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 1 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000536854 | + | 3 | 12 | 255_381 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 2 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000586397 | + | 1 | 10 | 137_254 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 1 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000586397 | + | 1 | 10 | 255_381 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 2 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000589228 | + | 2 | 11 | 137_254 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 1 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000589228 | + | 2 | 11 | 255_381 | 59.0 | 382.0 | Nucleotide binding | Note=cAMP 2 |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000358598 | + | 2 | 11 | 1_136 | 59.0 | 382.0 | Region | Note=Dimerization and phosphorylation |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000392711 | + | 2 | 11 | 1_136 | 59.0 | 382.0 | Region | Note=Dimerization and phosphorylation |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000536854 | + | 3 | 12 | 1_136 | 59.0 | 382.0 | Region | Note=Dimerization and phosphorylation |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000586397 | + | 1 | 10 | 1_136 | 59.0 | 382.0 | Region | Note=Dimerization and phosphorylation |
| Hgene | PRKAR1A | chr17:66511717 | chr13:80094945 | ENST00000589228 | + | 2 | 11 | 1_136 | 59.0 | 382.0 | Region | Note=Dimerization and phosphorylation |
| Tgene | NDFIP2 | chr17:66511717 | chr13:80094945 | ENST00000218652 | 0 | 8 | 1_231 | 107.0 | 1399.3333333333333 | Topological domain | Cytoplasmic |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| PRKAR1A | PRKAR1B, AKAP1, MYO7A, AKAP10, C2orf88, PLEKHF2, PYCARD, NPRL2, UBE2M, NUAK1, MCRS1, PRKACA, PRKAR1A, AKAP4, ARFGEF2, ARFGEF1, EGFR, GRB2, PRKX, AKAP11, Rrp1b, GABARAPL1, WNK1, UBC, PJA2, CBS, NELL2, C2orf44, BAHD1, ZBED1, MAPK6, TAB1, ELAVL1, SLC2A4, CUL3, PATZ1, PRKACB, PRPF31, SAFB, HSP90AA4P, MEN1, SLC38A5, Akap7, SMURF1, PRPF40A, SMAD2, CDK2, CCNE1, RFC2, PPP1CA, NPM1, SOX2, HIVEP1, CAPN11, SETD7, SET, DYRK1B, DYRK1A, GSK3B, ARPC3, PFDN5, AGO2, AGO3, CEP250, RAF1, CUL7, CCDC8, ILK, MTOR, BTRC, STOML2, PRKACG, PALM2-AKAP2, AKAP3, GPR161, ANKRD26, FRMD5, IFI16, XPO1, VAPA, Prkacb, Prkar2a, Gsk3b, VAPB, PRKAR2B, IQCB1, YWHAZ, DPB3, TCD1, EGLN3, HRAS, KRAS, NRAS, RECQL4, MCL1, MAPK12, TK1, FGFR3, FABP4, AGPAT1, MAP3K5, SPHK2, CANX, RC3H2, PLK1, BIRC3, NFX1, AKAP7, RSPH3, SPG20, DTX1, C11orf49, AKAP5, FAM153B, FBXW8, OBSL1, ARAF, BAD, MAPK7, AKAP12, HSPA8, HSPB1, JUP, PGAM5, GRWD1, AP3S1, RPL6, HIST1H1C, CORO1B, KHDRBS1, ADRM1, HIGD1A, SLC25A11, ROCK1, MEPCE, HIST1H1E, DOCK4, HIGD1C, GNL3, RPL36A, RPL8, STK39, GTF3C5, BCCIP, PDCD2L, UHRF1, ZFP91, GATAD2B, DDX42, CCDC108, LLGL2, SUZ12, USP10, C1QBP, NAP1L1, PYCR1, S100A7A, S100A7, MCM3, GART, EPB41L2, RBFOX3, RBFOX2, RBFOX1, CAMSAP3, FAT1, KDELR1, CFL1, G6PD, SERPINH1, SNRNP40, MAGEB2, HLA-C, HLA-A, COQ6, NXF1, VPS29, GPX8, MOB2, ACACA, AHSA1, MGEA5, AP1G1, ADAM10, PRKCA, PRKCB, PRKCI, PRKCZ, PTK6, RPS6KA3, SH3GL3, ESR1, MAP1LC3B, CDCA5, TULP3, SREBF2, nsp8ab, PTP4A3, ASXL1, DNAJB6, DNAJC28, OGT, KLHL28, EIF1AX, SBNO1, METTL15, FYN, SH3PXD2B, PLCB3, PAXBP1, NBR1, CALCOCO2, SQSTM1, |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| PRKAR1A |  |
| NDFIP2 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to PRKAR1A-NDFIP2 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to PRKAR1A-NDFIP2 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | PRKAR1A | C2607929 | Carney Complex, Type 1 | 10 | CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | PRKAR1A | C3276228 | ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE | 8 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | PRKAR1A | C0406810 | Carney Complex | 6 | CLINGEN;CTD_human;GENOMICS_ENGLAND |
| Hgene | PRKAR1A | C0220659 | Acrodysostosis | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
| Hgene | PRKAR1A | C0010481 | Cushing Syndrome | 2 | CTD_human |
| Hgene | PRKAR1A | C1864846 | PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1 (disorder) | 2 | CTD_human;GENOMICS_ENGLAND |
| Hgene | PRKAR1A | C0001627 | Congenital adrenal hyperplasia | 1 | CTD_human |
| Hgene | PRKAR1A | C0002170 | Alopecia | 1 | CTD_human |
| Hgene | PRKAR1A | C0020456 | Hyperglycemia | 1 | CTD_human |
| Hgene | PRKAR1A | C0021655 | Insulin Resistance | 1 | CTD_human |
| Hgene | PRKAR1A | C0023487 | Acute Promyelocytic Leukemia | 1 | CTD_human;ORPHANET |
| Hgene | PRKAR1A | C0026846 | Muscular Atrophy | 1 | CTD_human |
| Hgene | PRKAR1A | C0028754 | Obesity | 1 | CTD_human |
| Hgene | PRKAR1A | C0086873 | Pseudopelade | 1 | CTD_human |
| Hgene | PRKAR1A | C0162311 | Androgenetic Alopecia | 1 | CTD_human |
| Hgene | PRKAR1A | C0263477 | Female pattern alopecia (disorder) | 1 | CTD_human |
| Hgene | PRKAR1A | C0270948 | Neurogenic Muscular Atrophy | 1 | CTD_human |
| Hgene | PRKAR1A | C0920563 | Insulin Sensitivity | 1 | CTD_human |
| Hgene | PRKAR1A | C1850635 | Atrial myxoma, familial | 1 | CTD_human;ORPHANET |
| Hgene | PRKAR1A | C1854540 | Carney Complex, Type 2 | 1 | CTD_human |
| Hgene | PRKAR1A | C1855520 | Hyperglycemia, Postprandial | 1 | CTD_human |
| Hgene | PRKAR1A | C3553250 | ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE | 1 | CTD_human |
| Hgene | PRKAR1A | C3887949 | Apparent mineralocorticoid excess | 1 | CTD_human |
| Hgene | PRKAR1A | C4083212 | Alopecia, Male Pattern | 1 | CTD_human |
| Hgene | PRKAR1A | C4304832 | Primary pigmented nodular adrenocortical disease | 1 | ORPHANET |
| Hgene | PRKAR1A | C4721502 | Peripheral dysostosis | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies